Match-making for posaconazole through systems thinking
- 1 February 2015
- journal article
- Published by Elsevier in Trends in Parasitology
- Vol. 31 (2) , 46-51
Abstract
No abstract availableKeywords
This publication has 62 references indexed in Scilit:
- Randomized Trial of Posaconazole and Benznidazole for Chronic Chagas' DiseaseNew England Journal of Medicine, 2014
- Specific chemotherapy of Chagas disease: Relevance, current limitations and new approachesActa Tropica, 2010
- Chagas disease: a new worldwide challengeNature, 2010
- Functional Interactions between Sphingolipids and Sterols in Biological Membranes Regulating Cell PhysiologyMolecular Biology of the Cell, 2009
- Posaconazole Is a Potent Inhibitor of Sterol 14α-Demethylation in Yeasts and MoldsAntimicrobial Agents and Chemotherapy, 2004
- A Specific Structural Requirement for Ergosterol in Long-chain Fatty Acid Synthesis Mutants Important for Maintaining Raft Domains in YeastMolecular Biology of the Cell, 2002
- Current and Emerging Azole Antifungal AgentsClinical Microbiology Reviews, 1999
- Experimental chemotherapy with combinations of ergosterol biosynthesis inhibitors in murine models of Chagas' diseaseAntimicrobial Agents and Chemotherapy, 1993
- Susceptibility and natural resistance of Trypanosoma cruzi strains to drugs used clinically in Chagas diseaseTransactions of the Royal Society of Tropical Medicine and Hygiene, 1987
- Nova tripanozomiaze humana: estudos sobre a morfolojia e o ciclo evolutivo do Schizotrypanum cruzi n. gen., n. sp., ajente etiolojico de nova entidade morbida do homemMemórias do Instituto Oswaldo Cruz, 1909